Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience

Background & Aims: Hepatocellular Carcinoma (HCC) is the sixth most common malignancy and the third most common cause of cancer mortality worldwide. We aimed to assess the effect of novel treatment options on the survival of HCC patients. Methods: This retrospective study included all HCC patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Moore, Assaf, Cohen-Naftaly, Michal, Benjaminov, Ofer, Braun, Marius, Issachar, Assaf, Mor, Eitan, Tovar, Anna, Sarfaty, Michal, Gordon, Noa, Stemmer, Salomon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910579/
https://www.ncbi.nlm.nih.gov/pubmed/27313777
http://dx.doi.org/10.7150/jca.14721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910579/
https://www.ncbi.nlm.nih.gov/pubmed/27313777
http://dx.doi.org/10.7150/jca.14721

Ejemplares similares